Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
-
Catheter Cardiovasc Interv · Aug 2013
Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
With the expansion in the use of transcatheter valve therapies for aortic stenosis, the incidence of hemodynamically significant paravalvular regurgitation (PVR) has become a clinical challenge. ⋯ The management of PVR in the TAVR era is a technical challenge. We present our experience and propose a management approach.
-
Catheter Cardiovasc Interv · Aug 2013
Review Meta AnalysisGlycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction--a meta-regression of randomized controlled trials.
Recent studies have casted a doubt on usefulness of routine glycoprotein IIb/IIIA inhibitors (GPI) in patients, pretreated with aspirin and clopidogrel, undergoing primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI). ⋯ The benefit from GPI use in primary PCI for STEMI appears to depend on mortality risk, and not on thienopyridine pretreatment.
-
Catheter Cardiovasc Interv · Aug 2013
Case ReportsAortic aneurysm 18 month after transfemoral implantation of a self-expandable aortic valve prosthesis.
We report a case of a new developed aortic aneurysm 18 month after transcatheter aortic valve implantation in an 80-year-old woman. The abnormality was an incidental finding during routine coronary angiography.
-
Catheter Cardiovasc Interv · Aug 2013
Review Practice GuidelineMultisociety consensus quality improvement guidelines for intraarterial catheter-directed treatment of acute ischemic stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, European Society of Minimally Invasive Neurological Therapy, and Society of Vascular and Interventional Neurology.
In this international multispecialty document, quality benchmarks for processes of care and clinical outcomes are defined. It is intended that these benchmarks be used in a quality assurance program to assess and improve processes and outcomes in acute stroke revascularization. ⋯ Quality improvement guidelines are provided for endovascular acute ischemic stroke revascularization procedures.
-
Catheter Cardiovasc Interv · Aug 2013
Randomized Controlled TrialPatient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease.
Determine if patients prefer multivessel percutaneous coronary intervention (mv-PCI) over coronary artery bypass graft surgery (CABG) for treatment of symptomatic multivessel coronary artery disease (mv-CAD) despite high 1-year risk. ⋯ Patients favor mv-PCI over CABG to treat mv-CAD, even if 1-year risks of death and repeat procedures far exceed risk with CABG. Physicians are more influenced by actual risk and prefer mv-PCI less than patients despite similarly quoted 1-year risks.